TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.52, sa.5, ss.1551-1558, 2022 (SCI-Expanded)
Background/aim: We aimed to evaluate the efficacy of fulvestrant and its affecting clinical factors, including the optimal sequencing of fulvestrant and chemotherapy in a real-life cohort.